InventorsUS Classes424/208.1, Immunodeficiency virus (e.g., HIV, etc.)424/204.1, Virus or component thereof424/209.1, Orthomyxoviridae (e.g., influenza virus, fowl plague virus, etc.)424/221.1, Coronaviridae (e.g., neonatal calf diarrhea virus, feline infectious peritonitis virus, canine coronavirus, etc.)424/225.1, Hepatitis virus (e.g., infectious canine hepatitis virus, duck hepatitis virus, mouse hepatitis virus, etc.)424/229.1, Herpetoviridae (e.g., herpesvirus, Marek`s disease virus, laryngotracheitis virus, infectious bovine rhinotracheitis virus (IBR), infectious pustular vulvovaginitis virus, bovine herpes virus type 1, Aujeszky`s disease virus, feline rhinotracheitis virus, feline herpes virus, etc.)424/232.1, Poxviridae (e.g., smallpox virus, avian pox virus, fowlpox virus, rabbit myxoma virus, vaccinia virus, etc.)424/93.21, Eukaryotic cell424/529, Blood514/58Dextrin or derivativeAttorney, Agent or FirmInternational ClassesA61K 39/12A61K 39/21 A61K 39/145 A61K 39/215 A61K 39/29 A61K 39/245 A61K 39/275 A61K 35/26 A61K 35/14 A61K 31/724 Abstract textThis invention relates to cholesterol-sequestering agents and methods of using cholesterol-sequestering agents to treat or prevent infection. The compositions of the invention can be used in vitro or in vivo to decrease the load of a microorganism in a biological sample. Methods of generating an immune response against a microorganism are also included. |
| ||||||||||||||